--- title: "U.S. stock night market opening fluctuations: Soluna rose 13.48% in the night market; A SPAC III Acquisition rose 10.82% in the night market" type: "News" locale: "en" url: "https://longbridge.com/en/news/271444497.md" description: "Soluna rose 13.48% in after-hours trading; A SPAC III Acquisition rose 10.82% in after-hours trading; GH Research rose 19.71% in after-hours trading; Kazia Therapeutics rose 17.80% in after-hours trading; PBF Energy rose 17.25% in after-hours trading" datetime: "2026-01-05T01:20:53.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/271444497.md) - [en](https://longbridge.com/en/news/271444497.md) - [zh-HK](https://longbridge.com/zh-HK/news/271444497.md) --- # U.S. stock night market opening fluctuations: Soluna rose 13.48% in the night market; A SPAC III Acquisition rose 10.82% in the night market **U.S. Stock Night Market Opening Movements** Soluna, up 13.48% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. A SPAC III Acquisition, up 10.82% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. **Top Gainers in the U.S. Night Market** GH Research, up 19.71% in the night market. Based on recent key news: 1. On January 2, GH Research announced that it will update the research progress of its GH001 drug on January 5. This drug is used to treat treatment-resistant depression, and the company plans to share the latest status of its new drug application with the U.S. Food and Drug Administration (FDA) as well as the global key Phase III study. This news drove the stock price up 19% in after-hours trading. 2. On January 2, the company stated that it is working with experts to resolve remaining issues related to rat respiratory histology findings in its drug application. The company believes these findings are limited to rats, and this statement alleviated market concerns about drug safety, further supporting the stock price increase. 3. Over the past 12 months, GH Research's stock price has increased by 67%, demonstrating the market's continued confidence in its innovative depression treatments. The biopharmaceutical industry is active in the development of innovative drugs. Kazia Therapeutics, up 17.80% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. PBF Energy, up 17.25% in the night market. Based on recent key news: 1. On January 2, PBF Energy announced that the reconstruction work at its Martinez refinery in California will extend until February. Previously, due to a fire in February 2025, the restart plan for the refinery was postponed to March 2026. This news boosted market confidence in the company's future operational recovery, driving the stock price up. Source: Reuters 2. On January 2, PBF Energy released guidance for 2026, expecting to reach planned operating rates by March. The company has initiated the commissioning phase of public systems and some idle equipment and will gradually restart the refinery. This move shows the company's positive progress in restoring production, further enhancing investor confidence. Source: WSJ 3. On January 2, PBF Energy imported approximately 1.2 million barrels of Venezuelan crude oil, demonstrating its ability to handle heavy sour crude oil and improving raw material flexibility. This move is seen as a strategic adjustment in the company's raw material supply, enhancing market expectations for its long-term competitiveness. Source: Reuters Oil price volatility intensifies, and the industry faces challenges ### Related Stocks - [SLNH.US](https://longbridge.com/en/quote/SLNH.US.md) - [ASPC.US](https://longbridge.com/en/quote/ASPC.US.md) ## Related News & Research - [Soluna Holdings Boosts CEO Pay, Ties to Performance](https://longbridge.com/en/news/293803534.md) - [Soluna raises CEO John Belizaire base salary to $600,000 retroactive to Jan. 1, 2026](https://longbridge.com/en/news/293797512.md) - [Soluna names new chief to drive AI growth](https://longbridge.com/en/news/293016331.md) - [Soluna Forms Kati 2 JV With DC Kati Venture; Commits Up to $21M and 350 MW Plan](https://longbridge.com/en/news/289182479.md) - [Soluna Q1 net loss widens on higher compensation and financing expenses](https://longbridge.com/en/news/286764313.md)